nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Decitabine—Gemcitabine—pancreatic cancer	0.802	1	CrCrCtD
Entecavir—Didanosine—SLC29A1—pancreatic cancer	0.0114	1	CrCbGaD
Entecavir—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000907	0.00485	CcSEcCtD
Entecavir—Alopecia—Tamoxifen—pancreatic cancer	0.000889	0.00475	CcSEcCtD
Entecavir—Alopecia—Erlotinib—pancreatic cancer	0.000879	0.0047	CcSEcCtD
Entecavir—Mental disorder—Erlotinib—pancreatic cancer	0.000872	0.00466	CcSEcCtD
Entecavir—Pancreatitis—Irinotecan—pancreatic cancer	0.000869	0.00465	CcSEcCtD
Entecavir—Malnutrition—Erlotinib—pancreatic cancer	0.000866	0.00463	CcSEcCtD
Entecavir—Hepatitis—Sunitinib—pancreatic cancer	0.000861	0.00461	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—pancreatic cancer	0.000861	0.0046	CcSEcCtD
Entecavir—Oedema peripheral—Sunitinib—pancreatic cancer	0.000848	0.00454	CcSEcCtD
Entecavir—Neutropenia—Irinotecan—pancreatic cancer	0.000829	0.00443	CcSEcCtD
Entecavir—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.000824	0.0044	CcSEcCtD
Entecavir—Glycosuria—Epirubicin—pancreatic cancer	0.000813	0.00435	CcSEcCtD
Entecavir—Neutropenia—Gemcitabine—pancreatic cancer	0.000807	0.00432	CcSEcCtD
Entecavir—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000789	0.00422	CcSEcCtD
Entecavir—Hepatic failure—Docetaxel—pancreatic cancer	0.000789	0.00422	CcSEcCtD
Entecavir—Leukopenia—Tamoxifen—pancreatic cancer	0.000783	0.00419	CcSEcCtD
Entecavir—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000779	0.00416	CcSEcCtD
Entecavir—Immune system disorder—Sunitinib—pancreatic cancer	0.000778	0.00416	CcSEcCtD
Entecavir—Renal failure—Irinotecan—pancreatic cancer	0.000777	0.00415	CcSEcCtD
Entecavir—Alopecia—Sunitinib—pancreatic cancer	0.000761	0.00407	CcSEcCtD
Entecavir—Renal failure—Gemcitabine—pancreatic cancer	0.000757	0.00405	CcSEcCtD
Entecavir—Mental disorder—Sunitinib—pancreatic cancer	0.000754	0.00403	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—pancreatic cancer	0.000752	0.00402	CcSEcCtD
Entecavir—Malnutrition—Sunitinib—pancreatic cancer	0.00075	0.00401	CcSEcCtD
Entecavir—Haematuria—Gemcitabine—pancreatic cancer	0.000734	0.00392	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000732	0.00392	CcSEcCtD
Entecavir—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000728	0.00389	CcSEcCtD
Entecavir—Infection—Tamoxifen—pancreatic cancer	0.00071	0.0038	CcSEcCtD
Entecavir—Infection—Erlotinib—pancreatic cancer	0.000702	0.00376	CcSEcCtD
Entecavir—Nervous system disorder—Erlotinib—pancreatic cancer	0.000693	0.00371	CcSEcCtD
Entecavir—Skin disorder—Erlotinib—pancreatic cancer	0.000687	0.00367	CcSEcCtD
Entecavir—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000681	0.00364	CcSEcCtD
Entecavir—Leukopenia—Sunitinib—pancreatic cancer	0.000671	0.00359	CcSEcCtD
Entecavir—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000647	0.00346	CcSEcCtD
Entecavir—Insomnia—Tamoxifen—pancreatic cancer	0.000646	0.00346	CcSEcCtD
Entecavir—Immune system disorder—Irinotecan—pancreatic cancer	0.000641	0.00343	CcSEcCtD
Entecavir—Insomnia—Erlotinib—pancreatic cancer	0.000639	0.00342	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000634	0.00339	CcSEcCtD
Entecavir—Dyspepsia—Tamoxifen—pancreatic cancer	0.000629	0.00336	CcSEcCtD
Entecavir—Alopecia—Irinotecan—pancreatic cancer	0.000627	0.00335	CcSEcCtD
Entecavir—Immune system disorder—Gemcitabine—pancreatic cancer	0.000624	0.00334	CcSEcCtD
Entecavir—Dyspepsia—Erlotinib—pancreatic cancer	0.000622	0.00333	CcSEcCtD
Entecavir—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000617	0.0033	CcSEcCtD
Entecavir—Fatigue—Tamoxifen—pancreatic cancer	0.000616	0.00329	CcSEcCtD
Entecavir—Alopecia—Gemcitabine—pancreatic cancer	0.000611	0.00327	CcSEcCtD
Entecavir—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00061	0.00326	CcSEcCtD
Entecavir—Fatigue—Erlotinib—pancreatic cancer	0.000609	0.00326	CcSEcCtD
Entecavir—Infection—Sunitinib—pancreatic cancer	0.000608	0.00325	CcSEcCtD
Entecavir—Alopecia—Fluorouracil—pancreatic cancer	0.0006	0.00321	CcSEcCtD
Entecavir—Nervous system disorder—Sunitinib—pancreatic cancer	0.0006	0.00321	CcSEcCtD
Entecavir—Skin disorder—Sunitinib—pancreatic cancer	0.000594	0.00318	CcSEcCtD
Entecavir—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000584	0.00312	CcSEcCtD
Entecavir—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000578	0.00309	CcSEcCtD
Entecavir—Neutropenia—Docetaxel—pancreatic cancer	0.000573	0.00306	CcSEcCtD
Entecavir—Abdominal pain—Tamoxifen—pancreatic cancer	0.000565	0.00302	CcSEcCtD
Entecavir—Body temperature increased—Erlotinib—pancreatic cancer	0.000559	0.00299	CcSEcCtD
Entecavir—Abdominal pain—Erlotinib—pancreatic cancer	0.000559	0.00299	CcSEcCtD
Entecavir—Insomnia—Sunitinib—pancreatic cancer	0.000553	0.00296	CcSEcCtD
Entecavir—Leukopenia—Irinotecan—pancreatic cancer	0.000553	0.00296	CcSEcCtD
Entecavir—Dyspepsia—Sunitinib—pancreatic cancer	0.000539	0.00288	CcSEcCtD
Entecavir—Leukopenia—Gemcitabine—pancreatic cancer	0.000538	0.00288	CcSEcCtD
Entecavir—Renal failure—Docetaxel—pancreatic cancer	0.000537	0.00287	CcSEcCtD
Entecavir—Hepatic failure—Epirubicin—pancreatic cancer	0.000532	0.00285	CcSEcCtD
Entecavir—Leukopenia—Fluorouracil—pancreatic cancer	0.000529	0.00283	CcSEcCtD
Entecavir—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000528	0.00282	CcSEcCtD
Entecavir—Fatigue—Sunitinib—pancreatic cancer	0.000528	0.00282	CcSEcCtD
Entecavir—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000517	0.00276	CcSEcCtD
Entecavir—Asthenia—Tamoxifen—pancreatic cancer	0.000513	0.00274	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000509	0.00272	CcSEcCtD
Entecavir—Asthenia—Erlotinib—pancreatic cancer	0.000507	0.00271	CcSEcCtD
Entecavir—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000504	0.0027	CcSEcCtD
Entecavir—Infection—Irinotecan—pancreatic cancer	0.000501	0.00268	CcSEcCtD
Entecavir—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.0005	0.00268	CcSEcCtD
Entecavir—Nervous system disorder—Irinotecan—pancreatic cancer	0.000494	0.00264	CcSEcCtD
Entecavir—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000494	0.00264	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—pancreatic cancer	0.000492	0.00263	CcSEcCtD
Entecavir—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000491	0.00263	CcSEcCtD
Entecavir—Hepatitis—Docetaxel—pancreatic cancer	0.00049	0.00262	CcSEcCtD
Entecavir—Diarrhoea—Tamoxifen—pancreatic cancer	0.000489	0.00261	CcSEcCtD
Entecavir—Infection—Gemcitabine—pancreatic cancer	0.000488	0.00261	CcSEcCtD
Entecavir—Abdominal pain—Sunitinib—pancreatic cancer	0.000484	0.00259	CcSEcCtD
Entecavir—Body temperature increased—Sunitinib—pancreatic cancer	0.000484	0.00259	CcSEcCtD
Entecavir—Diarrhoea—Erlotinib—pancreatic cancer	0.000484	0.00259	CcSEcCtD
Entecavir—Oedema peripheral—Docetaxel—pancreatic cancer	0.000483	0.00258	CcSEcCtD
Entecavir—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000483	0.00258	CcSEcCtD
Entecavir—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000481	0.00257	CcSEcCtD
Entecavir—Infection—Fluorouracil—pancreatic cancer	0.00048	0.00256	CcSEcCtD
Entecavir—Skin disorder—Gemcitabine—pancreatic cancer	0.000477	0.00255	CcSEcCtD
Entecavir—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000473	0.00253	CcSEcCtD
Entecavir—Dizziness—Tamoxifen—pancreatic cancer	0.000472	0.00253	CcSEcCtD
Entecavir—Dizziness—Erlotinib—pancreatic cancer	0.000467	0.0025	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000457	0.00244	CcSEcCtD
Entecavir—Insomnia—Irinotecan—pancreatic cancer	0.000456	0.00244	CcSEcCtD
Entecavir—Vomiting—Tamoxifen—pancreatic cancer	0.000454	0.00243	CcSEcCtD
Entecavir—Rash—Tamoxifen—pancreatic cancer	0.00045	0.00241	CcSEcCtD
Entecavir—Dermatitis—Tamoxifen—pancreatic cancer	0.00045	0.00241	CcSEcCtD
Entecavir—Vomiting—Erlotinib—pancreatic cancer	0.000449	0.0024	CcSEcCtD
Entecavir—Somnolence—Irinotecan—pancreatic cancer	0.000448	0.0024	CcSEcCtD
Entecavir—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000448	0.0024	CcSEcCtD
Entecavir—Headache—Tamoxifen—pancreatic cancer	0.000448	0.00239	CcSEcCtD
Entecavir—Rash—Erlotinib—pancreatic cancer	0.000446	0.00238	CcSEcCtD
Entecavir—Dermatitis—Erlotinib—pancreatic cancer	0.000445	0.00238	CcSEcCtD
Entecavir—Insomnia—Gemcitabine—pancreatic cancer	0.000444	0.00237	CcSEcCtD
Entecavir—Dyspepsia—Irinotecan—pancreatic cancer	0.000444	0.00237	CcSEcCtD
Entecavir—Immune system disorder—Docetaxel—pancreatic cancer	0.000443	0.00237	CcSEcCtD
Entecavir—Headache—Erlotinib—pancreatic cancer	0.000443	0.00237	CcSEcCtD
Entecavir—Asthenia—Sunitinib—pancreatic cancer	0.000439	0.00235	CcSEcCtD
Entecavir—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000437	0.00234	CcSEcCtD
Entecavir—Insomnia—Fluorouracil—pancreatic cancer	0.000437	0.00233	CcSEcCtD
Entecavir—Somnolence—Gemcitabine—pancreatic cancer	0.000436	0.00233	CcSEcCtD
Entecavir—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000435	0.00233	CcSEcCtD
Entecavir—Fatigue—Irinotecan—pancreatic cancer	0.000435	0.00232	CcSEcCtD
Entecavir—Alopecia—Docetaxel—pancreatic cancer	0.000433	0.00232	CcSEcCtD
Entecavir—Mental disorder—Docetaxel—pancreatic cancer	0.00043	0.0023	CcSEcCtD
Entecavir—Somnolence—Fluorouracil—pancreatic cancer	0.000429	0.00229	CcSEcCtD
Entecavir—Malnutrition—Docetaxel—pancreatic cancer	0.000427	0.00228	CcSEcCtD
Entecavir—Dyspepsia—Fluorouracil—pancreatic cancer	0.000425	0.00227	CcSEcCtD
Entecavir—Nausea—Tamoxifen—pancreatic cancer	0.000424	0.00227	CcSEcCtD
Entecavir—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000424	0.00227	CcSEcCtD
Entecavir—Fatigue—Gemcitabine—pancreatic cancer	0.000423	0.00226	CcSEcCtD
Entecavir—Nausea—Erlotinib—pancreatic cancer	0.00042	0.00225	CcSEcCtD
Entecavir—Diarrhoea—Sunitinib—pancreatic cancer	0.000419	0.00224	CcSEcCtD
Entecavir—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000417	0.00223	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000414	0.00222	CcSEcCtD
Entecavir—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000412	0.0022	CcSEcCtD
Entecavir—Pancreatitis—Epirubicin—pancreatic cancer	0.000405	0.00217	CcSEcCtD
Entecavir—Dizziness—Sunitinib—pancreatic cancer	0.000405	0.00216	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000404	0.00216	CcSEcCtD
Entecavir—Abdominal pain—Irinotecan—pancreatic cancer	0.000398	0.00213	CcSEcCtD
Entecavir—Body temperature increased—Irinotecan—pancreatic cancer	0.000398	0.00213	CcSEcCtD
Entecavir—Vomiting—Sunitinib—pancreatic cancer	0.000389	0.00208	CcSEcCtD
Entecavir—Body temperature increased—Gemcitabine—pancreatic cancer	0.000388	0.00208	CcSEcCtD
Entecavir—Neutropenia—Epirubicin—pancreatic cancer	0.000386	0.00207	CcSEcCtD
Entecavir—Rash—Sunitinib—pancreatic cancer	0.000386	0.00206	CcSEcCtD
Entecavir—Dermatitis—Sunitinib—pancreatic cancer	0.000385	0.00206	CcSEcCtD
Entecavir—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000384	0.00205	CcSEcCtD
Entecavir—Headache—Sunitinib—pancreatic cancer	0.000383	0.00205	CcSEcCtD
Entecavir—Leukopenia—Docetaxel—pancreatic cancer	0.000382	0.00204	CcSEcCtD
Entecavir—Body temperature increased—Fluorouracil—pancreatic cancer	0.000382	0.00204	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—pancreatic cancer	0.000375	0.002	CcSEcCtD
Entecavir—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000373	0.00199	CcSEcCtD
Entecavir—Nausea—Sunitinib—pancreatic cancer	0.000363	0.00194	CcSEcCtD
Entecavir—Renal failure—Epirubicin—pancreatic cancer	0.000362	0.00194	CcSEcCtD
Entecavir—Asthenia—Irinotecan—pancreatic cancer	0.000362	0.00193	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000361	0.00193	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—pancreatic cancer	0.000358	0.00191	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000355	0.0019	CcSEcCtD
Entecavir—Asthenia—Gemcitabine—pancreatic cancer	0.000352	0.00188	CcSEcCtD
Entecavir—Haematuria—Epirubicin—pancreatic cancer	0.000351	0.00188	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000348	0.00186	CcSEcCtD
Entecavir—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000348	0.00186	CcSEcCtD
Entecavir—Infection—Docetaxel—pancreatic cancer	0.000346	0.00185	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000345	0.00184	CcSEcCtD
Entecavir—Diarrhoea—Irinotecan—pancreatic cancer	0.000345	0.00184	CcSEcCtD
Entecavir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000342	0.00183	CcSEcCtD
Entecavir—Skin disorder—Docetaxel—pancreatic cancer	0.000338	0.00181	CcSEcCtD
Entecavir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000336	0.0018	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—pancreatic cancer	0.000335	0.00179	CcSEcCtD
Entecavir—Dizziness—Irinotecan—pancreatic cancer	0.000333	0.00178	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—pancreatic cancer	0.000331	0.00177	CcSEcCtD
Entecavir—Diarrhoea—Fluorouracil—pancreatic cancer	0.00033	0.00177	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—pancreatic cancer	0.000326	0.00174	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—pancreatic cancer	0.000325	0.00174	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000322	0.00172	CcSEcCtD
Entecavir—Vomiting—Irinotecan—pancreatic cancer	0.00032	0.00171	CcSEcCtD
Entecavir—Dizziness—Fluorouracil—pancreatic cancer	0.000319	0.00171	CcSEcCtD
Entecavir—Rash—Irinotecan—pancreatic cancer	0.000318	0.0017	CcSEcCtD
Entecavir—Dermatitis—Irinotecan—pancreatic cancer	0.000317	0.0017	CcSEcCtD
Entecavir—Headache—Irinotecan—pancreatic cancer	0.000316	0.00169	CcSEcCtD
Entecavir—Insomnia—Docetaxel—pancreatic cancer	0.000315	0.00169	CcSEcCtD
Entecavir—Vomiting—Gemcitabine—pancreatic cancer	0.000312	0.00167	CcSEcCtD
Entecavir—Somnolence—Docetaxel—pancreatic cancer	0.00031	0.00166	CcSEcCtD
Entecavir—Rash—Gemcitabine—pancreatic cancer	0.00031	0.00166	CcSEcCtD
Entecavir—Dermatitis—Gemcitabine—pancreatic cancer	0.000309	0.00165	CcSEcCtD
Entecavir—Headache—Gemcitabine—pancreatic cancer	0.000308	0.00164	CcSEcCtD
Entecavir—Vomiting—Fluorouracil—pancreatic cancer	0.000307	0.00164	CcSEcCtD
Entecavir—Dyspepsia—Docetaxel—pancreatic cancer	0.000307	0.00164	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—pancreatic cancer	0.000306	0.00164	CcSEcCtD
Entecavir—Rash—Fluorouracil—pancreatic cancer	0.000304	0.00163	CcSEcCtD
Entecavir—Dermatitis—Fluorouracil—pancreatic cancer	0.000304	0.00163	CcSEcCtD
Entecavir—Headache—Fluorouracil—pancreatic cancer	0.000302	0.00162	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000301	0.00161	CcSEcCtD
Entecavir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000301	0.00161	CcSEcCtD
Entecavir—Fatigue—Docetaxel—pancreatic cancer	0.0003	0.00161	CcSEcCtD
Entecavir—Nausea—Irinotecan—pancreatic cancer	0.000299	0.0016	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—pancreatic cancer	0.000299	0.0016	CcSEcCtD
Entecavir—Alopecia—Epirubicin—pancreatic cancer	0.000292	0.00156	CcSEcCtD
Entecavir—Nausea—Gemcitabine—pancreatic cancer	0.000292	0.00156	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—pancreatic cancer	0.00029	0.00155	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—pancreatic cancer	0.000288	0.00154	CcSEcCtD
Entecavir—Nausea—Fluorouracil—pancreatic cancer	0.000287	0.00153	CcSEcCtD
Entecavir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000285	0.00152	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—pancreatic cancer	0.000276	0.00148	CcSEcCtD
Entecavir—Abdominal pain—Docetaxel—pancreatic cancer	0.000275	0.00147	CcSEcCtD
Entecavir—Body temperature increased—Docetaxel—pancreatic cancer	0.000275	0.00147	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—pancreatic cancer	0.00027	0.00145	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—pancreatic cancer	0.000268	0.00143	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—pancreatic cancer	0.000266	0.00142	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—pancreatic cancer	0.000258	0.00138	CcSEcCtD
Entecavir—Asthenia—Docetaxel—pancreatic cancer	0.00025	0.00134	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000243	0.0013	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—pancreatic cancer	0.000238	0.00128	CcSEcCtD
Entecavir—Diarrhoea—Docetaxel—pancreatic cancer	0.000238	0.00127	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000235	0.00126	CcSEcCtD
Entecavir—Infection—Epirubicin—pancreatic cancer	0.000233	0.00125	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—pancreatic cancer	0.00023	0.00123	CcSEcCtD
Entecavir—Dizziness—Docetaxel—pancreatic cancer	0.00023	0.00123	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—pancreatic cancer	0.000228	0.00122	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000225	0.0012	CcSEcCtD
Entecavir—Vomiting—Docetaxel—pancreatic cancer	0.000222	0.00118	CcSEcCtD
Entecavir—Rash—Docetaxel—pancreatic cancer	0.00022	0.00117	CcSEcCtD
Entecavir—Dermatitis—Docetaxel—pancreatic cancer	0.000219	0.00117	CcSEcCtD
Entecavir—Headache—Docetaxel—pancreatic cancer	0.000218	0.00117	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000217	0.00116	CcSEcCtD
Entecavir—Infection—Doxorubicin—pancreatic cancer	0.000216	0.00116	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000213	0.00114	CcSEcCtD
Entecavir—Insomnia—Epirubicin—pancreatic cancer	0.000213	0.00114	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—pancreatic cancer	0.000211	0.00113	CcSEcCtD
Entecavir—Somnolence—Epirubicin—pancreatic cancer	0.000209	0.00112	CcSEcCtD
Entecavir—Nausea—Docetaxel—pancreatic cancer	0.000207	0.00111	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—pancreatic cancer	0.000207	0.00111	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000203	0.00108	CcSEcCtD
Entecavir—Fatigue—Epirubicin—pancreatic cancer	0.000203	0.00108	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—pancreatic cancer	0.000197	0.00105	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—pancreatic cancer	0.000193	0.00103	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000192	0.00103	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—pancreatic cancer	0.000191	0.00102	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000188	0.001	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—pancreatic cancer	0.000187	0.001	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—pancreatic cancer	0.000186	0.000993	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—pancreatic cancer	0.000186	0.000993	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000178	0.000951	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—pancreatic cancer	0.000172	0.000919	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—pancreatic cancer	0.000172	0.000919	CcSEcCtD
Entecavir—Asthenia—Epirubicin—pancreatic cancer	0.000169	0.000902	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—pancreatic cancer	0.000161	0.00086	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—pancreatic cancer	0.000156	0.000834	CcSEcCtD
Entecavir—Dizziness—Epirubicin—pancreatic cancer	0.000155	0.000831	CcSEcCtD
Entecavir—Vomiting—Epirubicin—pancreatic cancer	0.000149	0.000799	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—pancreatic cancer	0.000149	0.000796	CcSEcCtD
Entecavir—Rash—Epirubicin—pancreatic cancer	0.000148	0.000792	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—pancreatic cancer	0.000148	0.000792	CcSEcCtD
Entecavir—Headache—Epirubicin—pancreatic cancer	0.000147	0.000787	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—pancreatic cancer	0.000144	0.000769	CcSEcCtD
Entecavir—Nausea—Epirubicin—pancreatic cancer	0.00014	0.000746	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—pancreatic cancer	0.000138	0.000739	CcSEcCtD
Entecavir—Rash—Doxorubicin—pancreatic cancer	0.000137	0.000733	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—pancreatic cancer	0.000137	0.000732	CcSEcCtD
Entecavir—Headache—Doxorubicin—pancreatic cancer	0.000136	0.000728	CcSEcCtD
Entecavir—Nausea—Doxorubicin—pancreatic cancer	0.000129	0.000691	CcSEcCtD
